...
首页> 外文期刊>Critical care nurse >Peripheral Intravenous Administration of High-Risk Infusions in Critical Care: A Risk-Benefit Analysis
【24h】

Peripheral Intravenous Administration of High-Risk Infusions in Critical Care: A Risk-Benefit Analysis

机译:外周静脉内施用高风险注入在重大关注:风险效益分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In critical care, the short peripheral intravenous catheter is an essential venous access route, often used in emergency situations to administer high-risk medications and fluid resuscitation. This route of administration is generally viewed as routine and benign. However, a growing body of evidence indicates that the risks inherent to this route are much higher than reported and represent a significant area of patient harm. Few standardized definitions and surveillance methods exist for peripheral intravenous catheter-related complications such as phlebitis, bloodstream infection, and extravasation. Recommendations for peripheral intravenous catheter replacement are based on clinical indications rather than routine replacement, so standards of practice for catheter insertion and management must be consistently applied. This article reviews recent studies that challenge the need for central catheter placement for vasopressor therapy, current knowledge of peripheral intravenous catheter-related adverse events, and evidence-based standards of care for short peripheral intravenous catheter insertion and maintenance.
机译:在关键护理中,短外周静脉导管是一种必不可少的静脉接入路线,通常用于泌尿情况,用于施用高风险药物和流体复苏。这次给药途径通常被视为常规和良性。然而,越来越多的证据表明该路线固有的风险远高于报告,代表了患者伤害的重要领域。存在少数标准化定义和监测方法,用于外周静脉内导管相关的并发症,如静脉炎,血液感染和脱发。外周静脉导管替代的建议基于临床适应症而不是常规更换,因此必须一致地应用导管插入和管理的实践标准。本文审查了最近的研究,挑战了对血管连接器治疗的中央导管展示的需求,目前对外周静脉内导管相关不良事件的知识以及短周围静脉内导管插入和维护的基于证据的护理标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号